Description
An investigational triple-receptor agonist targeting GIP, GLP-1, and glucagon pathways. Current research focuses on metabolic signaling, glucose regulation, energy balance, and related cardiometabolic markers.
For laboratory research only. Not for human or veterinary use. Research Use Policy